Research ArticleHIV

A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge

See allHide authors and affiliations

Science Translational Medicine  17 Jul 2019:
Vol. 11, Issue 501, eaaw2607
DOI: 10.1126/scitranslmed.aaw2607
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article